Education
About Us
Working with TipRanks
Follow Us
Gail Naughton Insider Profile
4 Followers
Gail Naughton, Director at CR Bard, holds 8.50K shares in TherapeuticsMD (Ticker: TXMD), holds 426.53K shares in Histogen (Ticker: HSTOQ), holds 0.00 shares in CR Bard (Ticker: BCR).
Profitable Transactions
1 out of 7 Profitable Transactions
Average Return
-15.10%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Gail Naughton holds in companies
Most Profitable Insider Trade
The most profitable trade made by Gail Naughton
Gail Naughton's Trading History
CR Bard
Jan 03, 2018
―
Uninformative Sell
―
$0.00
Histogen
May 28, 2020
Founder, Chief Scientific Officer & Chief Business
Uninformative Buy
―
$12.80K
TherapeuticsMD
Feb 20, 2025
Director
Uninformative Buy
8.67K
$7.39K
Cel-Sci
―
Director
―
―
Plus Therapeutics
Jun 15, 2016
Director
Informative Buy
2.10K
$65.94K
List of latest transactions for each holding click on a transaction to see Gail Naughton's performance on stock
You May Also Like
Gail Naughton insider profile FAQ
What is the percentage of profitable transactions made by Gail Naughton?
The percentage of profitable transactions made by Gail Naughton is 14%.
What is the average return per transaction made by Gail Naughton?
The average return per transaction made by Gail Naughton is -15.10%.
What stocks does Gail Naughton hold?
Gail Naughton holds: BCR, HSTOQ, TXMD, CVM, PSTV stocks.
What was Gail Naughton’s latest transaction?
Gail Naughton latest transaction was an Uninformative Buy of $8.67K.
What was Gail Naughton's most profitable transaction?
Gail Naughton’s most profitable transaction was an Informative Sell of TXMD stock on December 8, 2022. The return on the trade was 65.20%.
What is Gail Naughton's role in CR Bard?
Gail Naughton's role in CR Bard is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.